NPI registry status
Active
2026 NPPES data Neuropathology Physician NPI 1023247160 M.D.
Verify on CMS → Christopher Burris, M.D.
Neuropathology Physician in Washington, District of Columbia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 335 in Neuropathology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 269 beneficiaries · Neuropathology Physician avg: 365
Generic prescribing
69%
generic claims · 31% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Christopher Burris, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 1,025 Medicare Part D claims in 2024.
- 75/100
- CMS neutral score · not measured
- 1K
- Part D claims, 2024
- 69%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Christopher Burris, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1023247160), first enumerated 07/10/2009.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,025 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1023247160 · Neuropathology Physician
NPI-10 · ENUM-MID · TAX-TRACE · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1023247160
- ENUM-MID 2009
- TAX-TRACE 335
- MIPS-NEUTRAL 75/100
- RX-MID 1,025
- BOOK-THIN 6 in District of Columbia
- PHOTO-ENUM Cheng-Ying Ho, M.D.,… · 2009
Christopher Burris, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,025 ≥ 75th percentile 75% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Christopher Burris, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Christopher Burris, M.D.?
CMS neutral score, not measuredPrimary specialty
Neuropathology Physician
Medicare Part D claims
1,025 181% vs specialty avg
MIPS final score
75/100
Specialty distribution in District of Columbia
How Neuropathology Physician compares to other specialties among District of Columbia providers
MIPS score not measured
CMS assigned a neutral 75/100 threshold
CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1023247160 |
|---|---|
| Specialty | Neuropathology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/10/2009 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
CMS neutral threshold · not measured
Reporting: Group practice
Brand vs generic prescribing mix · Above average
Christopher Burris, M.D. - brand share 31.0%
Neuropathology Physician average
31% brand-name claims vs 69% generic, on 1,025 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,025
Total Claims
$111K
Total Drug Cost
269
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,520.133
- Total Day Supply
- 40,676
- Brand vs Generic
- 31% brand / 69% generic
- Brand Drug Cost
- $94K
- Generic Drug Cost
- $17K
- Antibiotic Claims
- 21
Patient Demographics
- Average Patient Age
- 71.9 years
- Avg HCC Risk Score
- 1.87
- Gender Split
- 63% female / 37% male
- Age Distribution
- <65: 49, 65-74: 117, 75-84: 78, 85+: 25
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Christopher Burris, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Latanoprost
Latanoprost
171 claims
- Neomycin-Polymyxin…
Neomycin-Polymyxin-Dexameth
155 claims
- Erythromycin
Erythromycin
153 claims
- Dorzolamide-Timolol
Dorzolamide-Timolol
87 claims
- Prednisolone Acetate
Prednisolone Acetate
82 claims
- Ketorolac Trometha… 63
Ketorolac Tromethamine
63 claims
- Xiidra 48
Xiidra
48 claims
- Brimonidine Tartrate 44
Brimonidine Tartrate
44 claims
| Drug | Claims |
|---|---|
| Latanoprost | 171 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 155 |
| Erythromycin Erythromycin Base | 153 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 87 |
| Prednisolone Acetate | 82 |
| Ketorolac Tromethamine | 63 |
| Xiidra Lifitegrast | 48 |
| Brimonidine Tartrate | 44 |
| Diclofenac Sodium | 27 |
| Cyclosporine | 26 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neuropathology Physician Overview
How Christopher Burris, M.D. fits within the Neuropathology Physician landscape nationally.
335
Neuropathology Physician Providers in US
43
States with Neuropathology Physician
365
Avg Claims per Provider
Christopher Burris, M.D.'s 1,025 claims are above the specialty average of 365.
Nationwide Neuropathology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Burris, both outside District of Columbia so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (75 here).
Same NPPES enumeration year (2009)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Neuropathology Physician Providers in District of Columbia
Other clinicians with the same primary specialty enrolled in District of Columbia, drawn from the same CMS NPPES roster as Burris.
One of 6 Neuropathology Physician providers enrolled in District of Columbia, 5 are shown here.
Dr. Maria Almira Suarez
MD
Washington, DC
Darius Amjadi
M.D. J.D.
Washington, DC
Dr. Lakshmi Ramachandran Nair
MD
Washington, DC
Elisabeth Rushing
Washington, DC
Dr. Glenn Sandberg
M.D.
Washington, DC
Compare Neuropathology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Christopher Burris, M.D.'s specialty? ▼
Christopher Burris, M.D. specializes in Neuropathology Physician and practices in Washington, District of Columbia. Credentials: M.D..
How much does Christopher Burris, M.D. prescribe under Medicare Part D? ▼
In 2024, Christopher Burris, M.D. wrote 1,025 Medicare Part D claims totaling $111K in drug costs for 269 beneficiaries.
What is Christopher Burris, M.D.'s Medicare quality score? ▼
Christopher Burris, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Christopher Burris, M.D. located? ▼
Christopher Burris, M.D. is located at 810 POTOMAC AVE SE, Washington, DC, 20003. Phone: (202) 878-6588.
What is Christopher Burris, M.D.'s NPI number? ▼
Christopher Burris, M.D.'s National Provider Identifier (NPI) is 1023247160, issued on 07/10/2009.
Does Christopher Burris, M.D. prescribe more brand-name or generic drugs? ▼
Christopher Burris, M.D.'s prescribing is 31% brand-name and 69% generic drugs by claim count, with $94K in brand drug costs.
How many Neuropathology Physician providers are there in the US? ▼
There are 335 Neuropathology Physician providers across 43 states in the US. The average Neuropathology Physician provider writes 365 Medicare Part D claims per year.
What drugs does Christopher Burris, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Christopher Burris, M.D.'s most frequently prescribed drugs include Latanoprost, Neomycin-Polymyxin-Dexameth, Erythromycin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Christopher Burris, M.D. accept Medicare? ▼
Christopher Burris, M.D. appears in CMS Medicare data with 1,025 Part D claims and 269 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Christopher Burris, M.D.'s credentials? ▼
Christopher Burris, M.D.'s NPI is 1023247160 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.